Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients

Improved prognostic stratification of patients with TNM stage II colorectal cancer (CRC) is desired, since 20–30% of high‐risk stage II patients may die within five years of diagnosis. This study was conducted to investigate REarranged during Transfection (RET) gene promoter CpG island methylation a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Oncol
Autori principali: Draht, Muriel X.G., Smits, Kim M., Tournier, Benjamin, Jooste, Valerie, Chapusot, Caroline, Carvalho, Beatriz, Cleven, Arjen H.G., Derks, Sarah, Wouters, Kim A.D., Belt, Eric J.T., Stockmann, Hein B.A.C., Bril, Herman, Weijenberg, Matty P., van den Brandt, Piet A., de Bruïne, Adriaan P., Herman, James G., Meijer, Gerrit A., Piard, Françoise, Melotte, Veerle, van Engeland, Manon
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2014
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528631/
https://ncbi.nlm.nih.gov/pubmed/24560444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.01.011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi